Rockwell Medical (RMTI) – StreetInsider.com Reports
-
Rockwell Medical (RMTI) Continues to Expand its Distribution Capabilities in Western US
-
Rockwell Medical (RMTI) Expands Global Distribution in the Dominican Republic and Bermuda
-
Rockwell Medical Technologies (RMTI) PT Lowered to $9 at H.C. Wainwright
-
Rockwell Medical (RMTI) Tops Q4 EPS by 9c ; Offers Guidance
-
Rockwell Medical (RMTI) Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund
-
Rockwell Medical (RMTI) Tops Q3 EPS by 4c
-
Rockwell Medical (RMTI) Appoints Jesse Neri as SVP of Finance
-
Rockwell Medical (RMTI) Appoints Joan Lau to its Board
-
Maxim Group Starts Rockwell Medical Technologies (RMTI) at Buy
-
Rockwell Medical (RMTI) Enters 3-Year Product Purchase Agreement with Centers for Dialysis Care
-
Rockwell Medical (RMTI) Enters 3-Year Product Purchase Agreement with Sanderling Renal Services
-
Rockwell Medical (RMTI) Enters into Products Purchase Agreement with its Largest Customer
-
Rockwell Medical (RMTI) and DaVita (DVA) Enter Restated Products Purchase Agreement
-
Rockwell Medical (RMTI) Announces 3.75M Share Offering by Selling Stockholders
-
Rockwell Medical (RMTI) Tops Q2 EPS by 11c, misses on revenue, provides guidance
-
Rockwell Medical Technologies (RMTI) PT Raised to $11 at H.C. Wainwright
-
Rockwell Medical (RMTI) Acquires Hemodialysis Concentrates Business from Evoqua Water Technologies
-
Rockwell Medical (RMTI) Enters 3-Year Co-Promotional Collaboration with B. Braun Medical
-
Rockwell Medical (RMTI) Added to Russell Microcap Index
-
Rockwell Medical Technologies (RMTI) PT Raised to $9 at H.C. Wainwright
-
Rockwell Medical (RMTI) Tops Q1 EPS by 12c
-
Rockwell Medical (RMTI) Announces Global Expansion into the UAE
-
Rockwell Medical's (RMTI) Partner Drogsan Pharmaceuticals Submits Marketing Authorization Application in Turkey for Triferic AVNU
-
Rockwell Medical (RMTI) and Concerto Renal Enter Three-Year, Multi-Million Dollar Product Purchase Agreement
-
Rockwell Medical Technologies (RMTI) PT Lowered to $7 at H.C. Wainwright
-
Rockwell Medical (RMTI) Signs Three-Year, Multi-Million Dollar Supply Agreement with Largest Non-Profit Dialysis Provider in the United States
-
Rockwell Medical (RMTI) Announces 1.4M Share Offering by Selling Stockholders
-
Rockwell Medical (RMTI) Issues Corporate and Clinical Update
-
Rockwell Medical (RMTI) Appoints Mark Strobeck as President and CEO
-
Rockwell Medical (RMTI) Regains Nasdaq Compliance
-
Rockwell Medical (RMTI) Announces $15 Million At-Market Offering of Common Stock, Warrants
-
Rockwell Medical (RMTI) Reports Q1 Loss of $0.84/sh
-
Rockwell Medical (RMTI) Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial
-
Rockwell Medical (RMTI) Announces 1-for-11 Reverse Stock Split
-
Rockwell Medical (RMTI) and DaVita (DVA) Expand Partnership
-
Rockwell Medical (RMTI) Announces Regulatory Approval of Triferic® Dialysate in South Korea
-
Rockwell Medical Technologies (RMTI) PT Lowered to $3 at H.C. Wainwright
-
Rockwell Medical (RMTI) Announced Approval of Triferic AVNU in South Korea
-
Rockwell Medical (RMTI) Receives Feedback from FDA on its IND Application for Phase 2 Trial of Ferric Pyrophosphate Citrate in Home Infusion
-
Pre-Open Stock Movers 11/17: (AVGR) (RMTI) (VRAR) Higher; (SAVA) (AVIR) (STNE) Lower (more...)
-
Rockwell Medical (RMTI) Study Demonstrates No Drug-drug Interaction Between Ferric Pyrophosphate Citrate and Unfractionated Heparin
-
Rockwell Medical (RMTI) Submits IND with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
-
Rockwell Medical Technologies (RMTI) PT Lowered to $5 at H.C. Wainwright
-
Rockwell Medical (RMTI) Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
-
Rockwell Medical (RMTI) Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates
-
Rockwell Medical (RMTI) and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic in Turkey
-
Rockwell Medical (RMTI) Announces Marketing Approval of Triferic AVNU in Canada
-
Rockwell Medical (RMTI) Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis
-
Rockwell Medical (RMTI) Reports Submission of Triferic NDA in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.
-
Rockwell Medical (RMTI) Reports First Patient Dosing in Pivotal Triferic Phase 3 Trial by Partner
Back to RMTI Stock Lookup